Top

Neurological Sciences

Published in:

01-05-2020 | Sleep Apnea | Original Article

The relationship between obstructive sleep apnea and Parkinson’s disease: a systematic review and meta-analysis

Authors: A-Ping Sun, Na Liu, Ying-Shuang Zhang, Hai-Yan Zhao, Xiao-Lu Liu

Published in: Neurological Sciences | Issue 5/2020

Abstract

Background

Obstructive sleep apnea (OSA) is a common sleep disorder in Parkinson’s disease (PD). However, the relationship between OSA and PD is still inconsistent. Our study was aimed to evaluate the relationship between PD and OSA.

Methods

Studies on OSA and PD were searched using PubMed, Embase, Web of Science, Cochrane library, and Chinese National Knowledge Infrastructure databases. Review Manager 5.3 software was used to calculate the pooled estimate effect. The inverse variance model was used to pool the mean difference (MD) or hazard ratios (HRs); the Mantel-Haenszel method was used to pool the odds ratio (OR). Heterogeneity among the studies was assessed using I² statistic and Q test.

Results

A total of 12 studies with 93,332 cases were deemed eligible and included in our meta-analysis. Overall, the occurrence of PD was more frequent in patients with OSA (HR 1.59, 95% CI, 1.36–1.85). The subgroup analysis demonstrated the risk similarly by sex. Male and female had HR of incident PD with OSA of 1.56 (95% CI, 1.30–1.87) and 1.60 (95% CI, 1.21–2.11), respectively. The incidence of OSA did not increase in PD patients (OR 0.89, 95% CI, 0.53–1.49). The MD of apnea-hypopnea index (AHI) in PD patients was also not statistically significant (P = 0.5).

Conclusions

The results indicate that OSA is one of independent risk factors of PD. However, OSA does not seem to be abnormally frequent in PD.

Santangelo G, Piscopo F, Barone P, Vitale C (2017) Personality in Parkinson’s disease: clinical, behavioural and cognitive correlates. J Neurol Sci 374:17–25. https://doi.org/10.1016/j.jns.2017.01.013 CrossRefPubMed

Charvin D, Medori R, Hauser RA, Rascol O (2018) Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs. Nat Rev Drug Discov 17(11):804–822. https://doi.org/10.1038/nrd.2018.136 CrossRefPubMed

Pagano G, Niccolini F, Fusar-Poli P, Politis M (2017) Serotonin transporter in Parkinson’s disease: a meta-analysis of positron emission tomography studies. Ann Neurol 81(2):171–180. https://doi.org/10.1002/ana.24859 CrossRefPubMed

Shimo Y, Hatano T, Sakurai M, Sekimoto S, Marisdina S, Hattori N (2019) Freezing of gait in Parkinson’s disease may share the mechanisms of dystonia. Neurol Sci:1–2. https://doi.org/10.1007/s10072-019-04155-0

Pelizzari L, Di Tella S, Lagana MM, Bergsland N, Rossetto F, Nemni R, Baglio F (2019) White matter alterations in early Parkinson’s disease: role of motor symptom lateralization. Neurol Sci:1–8. https://doi.org/10.1007/s10072-019-04084-y

Li T, Shi J, Qin B, Fan D, Liu N, Ni J, Zhang T, Zhou H, Xu X, Wei M, Zhang X, Wang X, Liu J, Wang Y, Tian J (2019) Increased substantia nigra echogenicity correlated with visual hallucinations in Parkinson’s disease: a Chinese population-based study. Neurol Sci:1–7. https://doi.org/10.1007/s10072-019-04110-z

Zeng XS, Geng WS, Jia JJ, Chen L, Zhang PP (2018) Cellular and molecular basis of neurodegeneration in Parkinson disease. Front Aging Neurosci 10:109. https://doi.org/10.3389/fnagi.2018.00109 CrossRefPubMedPubMedCentral

Kaminska M, Mery VP, Lafontaine AL, Robinson A, Benedetti A, Gros P, Kimoff RJ (2018) Change in cognition and other non-motor symptoms with obstructive sleep apnea treatment in Parkinson disease. J Clin Sleep Med 14(5):819–828. https://doi.org/10.5664/jcsm.7114 CrossRefPubMedPubMedCentral

Yoo SW, Kim JS, Oh YS, Ryu DW, Lee KS (2019) Excessive daytime sleepiness and its impact on quality of life in de novo Parkinson’s disease. Neurol Sci 40(6):1151–1156. https://doi.org/10.1007/s10072-019-03785-8 CrossRefPubMed

10.

Veasey SC, Rosen IM (2019) Obstructive sleep apnea in adults. N Engl J Med 380(15):1442–1449. https://doi.org/10.1056/NEJMcp1816152 CrossRefPubMed

11.

Dempsey JA, Veasey SC, Morgan BJ, O'Donnell CP (2010) Pathophysiology of sleep apnea. Physiol Rev 90(1):47–112. https://doi.org/10.1152/physrev.00043.2008 CrossRefPubMedPubMedCentral

12.

Parati G, Pengo MF, Lombardi C (2019) Obstructive sleep apnea and hypertension: why treatment does not consistently improve blood pressure. Curr Hypertens Rep 21(4):30. https://doi.org/10.1007/s11906-019-0935-x CrossRefPubMed

13.

Sharma S, Fox H, Aguilar F, Mukhtar U, Willes L, Bozorgnia B, Bitter T, Oldenburg O (2019) Positive airway pressure therapy reduces pulmonary hypertension in patients admitted for acute heart failure with pulmonary hypertension and obstructive sleep apnea. ASAP-HF Pilot Trial Sleep. https://doi.org/10.1093/sleep/zsz100

14.

Jehan S, Myers A, Zizi F, Pandi-Perumal S, Jean-Louis G, McFarlane S (2018) Obesity, obstructive sleep apnea and type 2 diabetes mellitus_ epidemiology and pathophysiologic insights. Sleep Med Disord 2(3):52–58PubMedPubMedCentral

15.

Heo SJ, Jun JS, Park D, Lee HW, Kim JS, Park JS (2019) Characteristics of obstructive sleep apnea in myasthenia gravis patients: a single center study. Neurol Sci 40(4):719–724. https://doi.org/10.1007/s10072-019-3706-1 CrossRefPubMed

16.

Ferini-Strambi L, Galbiati A, Combi R (2019) Sleep disorder-related headaches. Neurol Sci 40(Suppl 1):107–113. https://doi.org/10.1007/s10072-019-03837-z CrossRefPubMed

17.

Kawada T (2019) Obstructive sleep apnea and ischemic stroke: a risk assessment. Neurol Sci 40(10):2183. https://doi.org/10.1007/s10072-019-03946-9 CrossRefPubMed

18.

Mery V, Gros P, Lafontaine A, Robinson A, Benedetti A, Kimoff R, Kaminska M (2017) Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea. Neurology 88(12):1120–1128. https://doi.org/10.1212/WNL.0000000000003738 CrossRefPubMed

19.

Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, Bottacchi E, Cannas A, Ceravolo G, Ceravolo R, Cicarelli G, Gaglio RM, Giglia RM, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Dotto PD, PRIAMO study group (2009) The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord 24(11):1641–1649. https://doi.org/10.1002/mds.22643 CrossRefPubMed

20.

Cochen De Cock V, Abouda M, Leu S, Oudiette D, Roze E, Vidailhet M, Similowski T, Arnulf I (2010) Is obstructive sleep apnea a problem in Parkinson’s disease? Sleep Med 11(3):247–252. https://doi.org/10.1016/j.sleep.2009.05.008 CrossRefPubMed

21.

Yong MH, Fook-Chong S, Pavanni R, Lim LL, Tan EK (2011) Case control polysomnographic studies of sleep disorders in Parkinson’s disease. PLoS One 6(7):e22511. https://doi.org/10.1371/journal.pone.0022511 CrossRefPubMedPubMedCentral

22.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group P (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535. https://doi.org/10.1136/bmj.b2535 CrossRefPubMedPubMedCentral

23.

Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605. https://doi.org/10.1007/s10654-010-9491-z CrossRefPubMed

24.

Barut BO, Tascilar N, Varo A (2015) Sleep disturbances in essential tremor and Parkinson disease: a polysomnographic study. J Clin Sleep Med 11(6):655–662. https://doi.org/10.5664/jcsm.4778 CrossRefPubMedPubMedCentral

25.

Chen JC, Tsai TY, Li CY, Hwang JH (2015) Obstructive sleep apnea and risk of Parkinson’s disease: a population-based cohort study. J Sleep Res 24(4):432–437. https://doi.org/10.1111/jsr.12289 CrossRefPubMed

26.

Chou P-S, Lai C-L, Chou Y-H, Chang W-P (2017) Sleep apnea and the subsequent risk of Parkinson’s disease: a 3-year nationwide population-based study. Neuropsychiatr Dis Treat 13:959–965. https://doi.org/10.2147/ndt.S134311 CrossRefPubMedPubMedCentral

27.

Crosta F, Desideri G, Marini C (2017) Obstructive sleep apnea syndrome in Parkinson’s disease and other parkinsonisms. Funct Neurol 32(3):137–141CrossRefPubMedPubMedCentral

28.

Diederich NJ, Vaillant M, Leischen M, Mancuso G, Golinval S, Nati R, Schlesser M (2005) Sleep apnea syndrome in Parkinson’s disease. A case-control study in 49 patients. Mov Disord 20(11):1413–1418. https://doi.org/10.1002/mds.20624 CrossRefPubMed

29.

Happe S, Schrodl B, Faltl M, Muller C, Auff E, Zeitlhofer J (2001) Sleep disorders and depression in patients with Parkinson’s disease. Acta Neurol Scand 104(5):275–280. https://doi.org/10.1034/j.1600-0404.2001.00024.x CrossRefPubMed

30.

Lynn Marie Trotti M, Donald L, Bliwise P (2010) Split-screen video demonstration of sonography-guided muscle identification and injection of botulinum toxin. Mov Disord 25(13):2225–2228. https://doi.org/10.1002/mds.23113 CrossRef

31.

Maria B, Sophia S, Michalis M, Charalampos L, Andreas P, John ME, Nikolaos SM (2003) Sleep breathing disorders in patients with idiopathic Parkinson’s disease. Respir Med 97(10):1151–1157CrossRefPubMed

32.

Sheu JJ, Lee HC, Lin HC, Kao LT, Chung SD (2015) A 5-year follow-up study on the relationship between obstructive sleep apnea and Parkinson disease. J Clin Sleep Med 11(12):1403–1408. https://doi.org/10.5664/jcsm.5274 CrossRefPubMedPubMedCentral

33.

Yeh NC, Tien KJ, Yang CM, Wang JJ, Weng SF (2016) Increased risk of Parkinson’s disease in patients with obstructive sleep apnea: a population-based, propensity score-matched, longitudinal follow-up study. Medicine (United States) 95(2):e2293. https://doi.org/10.1097/MD.0000000000002293 CrossRef

34.

Zoccolella S, Savarese M, Lamberti P, Manni R, Pacchetti C, Logroscino G (2011) Sleep disorders and the natural history of Parkinson’s disease: the contribution of epidemiological studies. Sleep Med Rev 15(1):41–50. https://doi.org/10.1016/j.smrv.2010.02.004 CrossRefPubMed

35.

Braga-Neto P, Pereira da Silva-Júnior F, Sueli Monte F, de Bruin PFC, de Bruin VMS (2004) Snoring and excessive daytime sleepiness in Parkinson’s disease. J Neurol Sci 217(1):41–45. https://doi.org/10.1016/j.jns.2003.08.010 CrossRefPubMed

36.

Miller RL, James-Kracke M, Sun GY, Sun AY (2009) Oxidative and inflammatory pathways in Parkinson’s disease. Neurochem Res 34(1):55–65. https://doi.org/10.1007/s11064-008-9656-2 CrossRefPubMed

37.

Hernandez-Romero MC, Delgado-Cortes MJ, Sarmiento M, de Pablos RM, Espinosa-Oliva AM, Arguelles S, Bandez MJ, Villaran RF, Maurino R, Santiago M et al (2012) Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system. Neurotoxicology 33(3):347–360. https://doi.org/10.1016/j.neuro.2012.01.018 CrossRefPubMed

38.

Hunot S, Hirsch EC (2003) Neuroinflammatory processes in Parkinson’s disease. Ann Neurol 53(Suppl 3):S49–S58; discussion S58-60. https://doi.org/10.1002/ana.10481 CrossRefPubMed

39.

Pamidi S, Tasali E (2012) Obstructive sleep apnea and type 2 diabetes: is there a link? Front Neurol 3:126. https://doi.org/10.3389/fneur.2012.00126 CrossRefPubMedPubMedCentral

40.

Nieto FJ (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Jama 283(14):1829–1836. https://doi.org/10.1001/jama.283.14.1829 CrossRefPubMed

41.

Drager LF, Jun J, Polotsky VY (2010) Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 17(2):161–165. https://doi.org/10.1097/MED.0b013e3283373624 CrossRefPubMedPubMedCentral

42.

Thanvi B, Lo N, Robinson T (2005) Vascular parkinsonism--an important cause of parkinsonism in older people. Age Ageing 34(2):114–119. https://doi.org/10.1093/ageing/afi025 CrossRefPubMed

43.

Benamer HT, Grosset DG (2009) Vascular parkinsonism: a clinical review. Eur Neurol 61(1):11–15. https://doi.org/10.1159/000165343 CrossRefPubMed

Title: The relationship between obstructive sleep apnea and Parkinson’s disease: a systematic review and meta-analysis
Authors: A-Ping Sun
Na Liu
Ying-Shuang Zhang
Hai-Yan Zhao
Xiao-Lu Liu
Publication date: 01-05-2020
Publisher: Springer International Publishing
Keywords: Sleep Apnea
Polysomnography
Parkinson's Disease
Published in: Neurological Sciences / Issue 5/2020
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-019-04211-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The relationship between obstructive sleep apnea and Parkinson’s disease: a systematic review and meta-analysis

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 5/2020

Serum adiponectin levels between patients with Parkinson’s disease and those with PSP

Comprehension of written texts for the assessment of clinical competence and decision making in people with mild to moderate Alzheimer disease

A case of metabolic encephalopathy associated with euglycemic diabetic ketoacidosis

Steroid-responsive myositis in a patient with Sjögren’s syndrome and refractory peripheral neuropathy

The role of noninvasive brain stimulation for behavioral and psychological symptoms of dementia: a systematic review and meta-analysis

Recent progress in neuronal intranuclear inclusion disease: a review of the literature